No Data
Olin Bio (688319.SH): received government subsidies of 2.24 million yuan.
On November 28, Gelonghui reported that olin biology (688319.SH) announced that its wholly-owned subsidiary Chongqing Yuanlun Biological Technology Co., Ltd. recently received government subsidies totaling 2.24 million yuan, of which 2.24 million yuan is related to income and 0 yuan is related to assets.
Chengdu Olin Biotechnology Co., Ltd. Report for the Third Quarter of 2024
Olin Biology (688319.SH): The proposed additional fundraising will not exceed 0.3 billion yuan.
On October 29, Gelonhui announced that Olin Biotech (688319.SH) disclosed that the total amount of funds raised by the company in this issuance of stocks shall not exceed 175.2929 million yuan (including this amount), not more than 0.3 billion yuan and not more than 20% of the net assets at the end of the most recent year. The net proceeds from the funds raised after deducting the relevant issuance expenses are intended to be invested in the following project: the technical renovation project of the vaccine R&D production base.
Express News | Olin Biosciences: net income in the third quarter was 31.9729 million yuan, a year-on-year increase of 1739.97%.
Olin Biosciences (688319.SH): The net income in the first three quarters was 4.0259 million yuan, a year-on-year decrease of 86.71%.
Gelonghui October 29th news｜Olin Biology (688319.SH) announced the third quarter report of 2024, the company's revenue for the first three quarters of the year was 0.387 billion yuan, a year-on-year increase of 9.75%; net income attributable to shareholders of listed companies was 4.0259 million yuan, a year-on-year decrease of 86.71%; basic earnings per share were 0.0099 yuan.
Olin Biology (688319.SH): Trivalent Influenza Virus Split Vaccine (MDCK Cells) Approved for Clinical Trials
Olin Biology (688319.SH) announced that the company recently received the approval and issuance from the National Medical Products Administration...
No Data
